Company: THC
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0000070318-25-000009
Chunk: 122

Company: TENET HEALTHCARE CORP
Filing Date: 2025-02-18
Form: 10-K
Item: Item 8
Chunk 122
---
 October 1 through October 31, 2024—$— —$2 November 1 through November 30, 2024—$— —$2 December 1 through December 31, 2024—$— —$2 Year ended December 31, 20244,801$114.19 4,8012024 Share Repurchase ProgramIn July 2024, our board of directors authorized the repurchase of up to $1.500 billion of our common stock through a share repurchase program that has no expiration date (the “2024 share repurchase program”). Similar to the 2022 share repurchase program, repurchases under the 2024 program may be made in open‑market or privately negotiated transactions, at management’s discretion subject to market conditions and other factors, and in a manner consistent with applicable securities 

87

Table of Contents

laws and regulations. The 2024 share repurchase program does not obligate us to acquire any particular amount of common stock, and it may be suspended for periods or discontinued at any time.The following table presents transactions completed under the 2024 share repurchase program during the periods shown:PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced ProgramMaximum Dollar Value of Shares That May Yet be Purchased Under the Program (In Thousands)(In Thousands)(In Millions)Inception through July 31, 2024—$— —$1,500 August 1 through August 31, 2024—$— —$1,500 September 1 through September 30, 2024795$155.95 795$1,376 October 1 through October 31, 2024—$— —$1,376 November 1 through November 30, 2024—$— —$1,376 December 1 through December 31, 2024—$— —$1,376 Inception through December 31, 2024795$155.95 795

NOTE 3. ACCOUNTS RECEIVABLE

The principal components of accounts receivable are presented in the table below:December 31, 20242023Patient accounts receivable$2,386 $2,719 Estimated future recoveries144 148 Net cost reports and settlements receivable and valuation allowances6 47 Accounts